However, these simpler methods for assessing Ki-67 have so far received less attention from the IKWG compared to their previously described manual counting and weighted average method [2], which undoubtedly better reflects the biological variability of breast cancer but may not be strictly necessary to divide patients into clinically useful categories. The gene discussed is MKI67; the disease is breast carcinoma.